Unmet Needs in the Treatment of Gastroesophageal Reflux Disease
Author:
Affiliation:
1. The Esophageal and Swallowing Center, Division of Gastroenterology and Hepatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio, USA
Publisher
The Korean Society of Neurogastroenterology and Motility
Subject
Gastroenterology,Clinical Neurology
Link
http://pdf.medrang.co.kr/JNM2/2015/021/jnm-21-309.pdf
Reference117 articles.
1. Burden of Gastrointestinal Disease in the United States: 2012 Update
2. Nonerosive Reflux Disease (NERD) - An Update
3. The Role of Proton Pump Inhibitors in Gastro-oesophageal Reflux Disease
4. Coron, E, Hatlebakk, JG, and Galmiche, JP (2007). Medical therapy of gastroesophageal reflux disease. Curr Opin Gastroenterol. 23, 434-439.
5. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A systematic review and meta‐analysis of the efficacy of vonoprazan for proton pump inhibitor‐resistant gastroesophageal reflux disease;Journal of Gastroenterology and Hepatology;2024-01-23
2. Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study;BMC Gastroenterology;2023-12-18
3. Efficacy and Safety of HIP1601 (Dual Delayed-release Esomeprazole) 40mg in Erosive Esophagitis Compared to HGP1705 (Delayed-release Esomeprazole) 40mg: A Multicenter, Randomized, Double-blind, Non-inferiority Study;2023-10-17
4. Randomised clinical trial: Efficacy and safety of on‐demand vonoprazan versus placebo for non‐erosive reflux disease;Alimentary Pharmacology & Therapeutics;2023-09-26
5. Carcinogenicity assessment of tegoprazan in Sprague-Dawley (Crl:CD) rats and ICR (Crl:CD1) mice;Regulatory Toxicology and Pharmacology;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3